Fludarabine with cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with poor-risk chronic lymphocytic leukemia

Warning

This publication doesn't include Faculty of Economics and Administration. It includes Central European Institute of Technology. Official publication website can be found on muni.cz.

Authors	KREJČÍ Marta DOUBEK Michael BRYCHTOVÁ Yvona STEHLÍKOVÁ Olga CHOVANCOVÁ Jana TICHÝ Boris SKUHROVÁ FRANCOVÁ Hana NAVRÁTIL Milan TOMIŠKA Miroslav HORKÝ Ondřej POSPÍŠILOVÁ Šárka MAYER Jiří
Year of publication	2013
Type	Article in Periodical
Magazine / Source	Annals of hematology
MU Faculty or unit	Central European Institute of Technology
Citation
Web	http://www.deepdyve.com/lp/springer-journals/fludarabine-with-cytarabine-followed-by-reduced-intensity-conditioning-9ZWkbtzzaM
Doi	http://dx.doi.org/10.1007/s00277-012-1579-y
Field	Oncology and hematology
Keywords	chronic lymphocytic leukemia; reduced-intensity conditioning; fludarabine; cytarabine
Attached files	EL_1082993_Fludarabine_with_cytarabine.pdf
Description	Allogeneic stem cell transplantation (SCT) is a treatment option for patients with poor-risk chronic lymphocytic leukemia (CLL).Sequential use of chemotherapy and reduced-intensity conditioning has been proposed to improve the treatment outcomes.
Related projects:	Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies Real-time PCR soupravy pro diagnostiku v onkologii SuPReMMe - Podpora profesního růstu a mezinárodní integrace výzkumných týmů v oblasti molekulární medicíny CEITEC - Central European Institute of Technology